BrainScope discovers EEG-based biomarker predicts dementia risk 5-7 years prior to diagnosis, published in Nature.

A recent study conducted by BrainScope in Rockville, Maryland, showcased the effectiveness of their EEG-based biomarker in predicting cognitive decline up to 5 to 7 years before diagnosis. The research highlights the potential of this technology to identify individuals at risk of cognitive impairment before symptoms manifest. This development signifies a significant advancement in early detection of cognitive decline and holds promise for proactive intervention strategies.